Description
Quanta Retatrutide 50mg
Quanta Pharma Retatrutide 50mg is a triple agonist, meaning it activates three metabolic hormone receptors at once, GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and Glucagon receptors.
This triple action distinguishes it from peptides like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro), which target only one or two of those hormones.
Here are the main benefits for bodybuilders using retatrutide for removing body fat.
Greater Weight Loss Potential
Clinical trials in 2023 showed average weight reductions of up to ~24% of body weight after 48 weeks, a level approaching what’s seen with bariatric surgery.
This is higher than semaglutide (~15%) or tirzepatide (~22%) in comparable timeframes.
Retatrutide Improves Metabolic Health
Retatrutide improves multiple metabolic markers, better blood glucose control, reduced insulin resistance and lower fasting glucose, improvements in cholesterol and triglycerides and decreased liver fat, which reduces the risk of fatty liver disease.
Enhances Fat Burning and Energy Expenditure
Because retatrutide activates glucagon receptors, it increase energy expenditure, promotes fat oxidation and helps to preserve lean muscle mass compared to some other GLP-1 peptides.
Controls Appetite and Cravings
Like other GLP-1 peptides, retatrutide acts on the brain’s satiety centres to reduce appetite and food cravings, particularly for high-calorie foods and prolong feelings of fullness after eating smaller portions.
Benefits The Cardiovascular System
Quanta Retarutide reduces blood pressure and inflammation, lowers cardiovascular risk reduction similar to GLP-1 peptides and Improves liver enzymes and fat content, which benefits fatty liver disease.
